National Council for Prescription Drug Programs indexing - billing unit

Manufacturer
National Council for Prescription Drug Programs
Effective date
2012-07-24
Label type
Indexing - Billing Unit
Version
1
Source
full-release
Hydrated at
2026-06-05 02:37:59

Label at a glance#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
55289-265-90EA - Each55289-265c57793e4-8855-443a-9f0d-7a4239df290812012-07-24

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
55289-26555289-265-90

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A070259-001TOLAZAMIDETOLAZAMIDE250MGTABLET / ORAL1986-01-02
A070259-003TOLAZAMIDETOLAZAMIDE500MGTABLET / ORAL1986-03-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-0284e616aacf4f…
2026-09-14 22:38:342026-08A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-1784e616aacf4f…
2026-08-18 06:07:402026-07A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-02caaa826d4ba7…
2026-08-18 06:07:402026-07A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-17caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-17011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-1731067a03dcf5…
2025-08-23 18:47 UTC2025-08A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-026a471c1ec25d…
2025-08-23 18:47 UTC2025-08A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-176a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-02fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-17fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-02b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-17b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-0203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-1703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-022680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-172680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-025bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-175bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-02d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-17d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-02d06236e962d9…
2024-10-29 15:01 UTC2024-10A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-17d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-0279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-1779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-02301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-17301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-021e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-171e350fbaab3a…
2024-05-31 18:47 UTC2024-05A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-028072bd15b7f6…
2024-05-31 18:47 UTC2024-05A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-178072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-025c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-175c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-025d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-175d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-024b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A070259-003TOLAZAMIDE500MGTABLET / ORAL1986-03-174b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A070259-001TOLAZAMIDE250MGTABLET / ORAL1986-01-0274a2ff9319b5…
2019-12-13 00:20 UTC2019-12A070259-003TOLAZAMIDE500MGTABLET / ORALRS1986-03-1774a2ff9319b5…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.